BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zwain A, Aldiwani M, Taqi H. The Association Between Psoriasis and Cardiovascular Diseases. Eur Cardiol 2021;16:e19. [PMID: 34040653 DOI: 10.15420/ecr.2020.15.R2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Trovato E, Rubegni P, Prignano F. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome. Expert Opin Biol Ther 2022;22:1443-8. [PMID: 35726639 DOI: 10.1080/14712598.2022.2093106] [Reference Citation Analysis]
2 Olszewski R, Ćwiklińska K, Maślińska M, Kwiatkowska B. Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis. Reumatologia 2022;60:266-74. [PMID: 36186830 DOI: 10.5114/reum.2022.119043] [Reference Citation Analysis]
3 Gupta A, Madke B. Psoriasis a Cause of Cardiovascular Diseases: A Review Article. Cureus 2022. [DOI: 10.7759/cureus.27767] [Reference Citation Analysis]
4 Midtbø H, Kringeland E, Gerdts E, Ueland PM, Meyer K, Linde A, Ulvik A, Jonsson R, Tveit KS. Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab. Int J Immunopathol Pharmacol 2022;36:3946320221111131. [PMID: 35968808 DOI: 10.1177/03946320221111131] [Reference Citation Analysis]
5 Chen TL, Lee LL, Huang HK, Wang JH, Chen LY, Tsai HR, Loh CH, Chi CC. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease: A Systematic Review and Meta-analysis. JAMA Dermatol 2021. [PMID: 34851364 DOI: 10.1001/jamadermatol.2021.4918] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]